ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FFWD Fastforward Innovations Limited

8.25
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fastforward Innovations Limited LSE:FFWD London Ordinary Share GG00BRK9BQ81 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.25 8.00 8.50 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

FastForward Innovations Limited Investee Company Update: Nuuvera (7880B)

12/01/2018 3:43pm

UK Regulatory


Fastforward Innovations (LSE:FFWD)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Fastforward Innovations Charts.

TIDMFFWD

RNS Number : 7880B

FastForward Innovations Limited

12 January 2018

The following amendment has been made to the 'Investee Company Update: Nuuvera' announcement released on 12 January 2018 at 2.23pm under RNS No 7794B.

In the first paragraph it should have read 'FastForward is pleased to note the announcement by investee company Nuuvera Corp. ("Nuuvera" (TSXV: NUU)), a public company formed to capitalize on the global trend towards the legalization..... In the original announcement Nuuvera was described as 'a privately held company formed....'.

All other details remain unchanged.

The full amended text is shown below.

12 January 2018

FastForward Innovations Limited

("FastForward"")

Investee Company Update: Nuuvera agrees MOU with the Province of New Brunswick to supply 2.5 million grams of cannabis and related products for the province's cannabis market.

FastForward is pleased to note the announcement by investee company Nuuvera Corp. ("Nuuvera" (TSXV: NUU)), a public company formed to capitalize on the global trend towards the legalization of medical cannabis, in which FastForward has a holding of 3.75%, today, that it has entered into a Memorandum of Understanding ("MOU") with the Province of New Brunswick to supply 2.5 million grams of cannabis and related products for the province's cannabis market. The Nuuvera announcement reads as follows:

'Nuuvera Inc. ("Nuuvera") (TSXV:NUU) announced that it has entered into a Memorandum of Understanding ("MOU") with the Province of New Brunswick to supply 2.5 million grams of cannabis and related products for the province's cannabis market.

The MOU sets the groundwork for Nuuvera to supply high-quality cannabis oil and flower to the province, beginning in July 2018. Included in the agreement is Nuuvera's commitment to donate two-percent of the gross value of cannabis products sold to the government to the Cannabis Education and Awareness Fund.

Lorne Abony, CEO of Nuuvera, said that the MOU signals Nuuvera's growing participation in Canada's cannabis industry.

"We are pleased to finalise this important MOU with New Brunswick. Not only is it the result of productive and open negotiations, but it is an endorsement of the way Nuuvera operates and what we stand for. We will keep working with the Government of New Brunswick, and governments across Canada, to help create a safe, high-quality industry that meets the needs of all cannabis consumers."

In addition to the MOU, Nuuvera also announced this week that it would establish a state-of-the-art laboratory in Saint John that will process, manufacture and distribute pharmaceutical-grade medical marijuana derivative products. This will be Nuuvera's second such facility in Canada and will create new, skilled jobs for the city.

"With offices in Toronto, Tel Aviv, Hamburg, and Milan, we are positioned to serve diversified international markets with medical grade cannabis products, and our New Brunswick operations will form a critical piece of our research and development efforts that will keep us on the leading edge of product innovation," said Abony.'

For more information on Nuuvera, please visit: www.nuuvera.com

About Nuuvera

Nuuvera is a global medical cannabis company founded on Canadian principles, and built with the whole world in mind. Nuuvera is currently working with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets. Through its subsidiaries, ARA - Avanti Rx Analytics Inc. and Avalon Pharmaceutical Inc., Nuuvera holds a Dealer License (GMP) under the Narcotic Control Regulations and Office of Controlled Substances. Nuuvera is currently in the final stages of the Health Canada review process to become a Licensed Producer of medical marijuana under the ACMPR, and has recently received its "letter to build" approval.

For further information please visit www.fstfwd.co or contact:

 
FastForward Innovations Limited info@fstfwd.co 
 Sue Saunders/ Ian Burns 
------------------------------------------------------------ 
Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396 
 James Biddle / Roland Cornish 
------------------------------------------------------------ 
Optiva Securities Limited (Broker) Tel: +44 (0) 203 411 1881 
 Ed McDermott 
------------------------------------------------------------ 
 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

UPDUUSVRWUAAAAR

(END) Dow Jones Newswires

January 12, 2018 10:43 ET (15:43 GMT)

1 Year Fastforward Innovations Chart

1 Year Fastforward Innovations Chart

1 Month Fastforward Innovations Chart

1 Month Fastforward Innovations Chart

Your Recent History

Delayed Upgrade Clock